logo

For the Inventor, By the Inventor

Azumino, Japan

Kazuo Shimizu

This inventor holds 21 USPTO granted patents and 7 EPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Kissei Pharmaceutical Co., Ltd.. Active years: 2008-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuo Shimizu. Retrieved from https://idiyas.com/inventor/kazuo-shimizu-bcahqbq8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21

% Patents Active = 38.1

 

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 103(Granted Patents)


Location History:

  • Hotaka-machi, JP (2008 - 2009)
  • Nagano, JP (2009 - 2012)
  • Azumino, JP (2008 - 2018)

Company Filing History:

goldMedal21 out of 176 
 
Kissei Pharmaceutical Co., Ltd.
 patents

Years Active: 2008-2018

Loading Chart...
Loading Chart...
Areas of Expertise:
Carboxymethyl Piperidine
Cyclohexyl Pyridine
Indolizine Derivative
Fused Heterocyclic
Pyrazole Derivative
Nitrogenous Fused-Ring
Medicinal Composition
Pharmaceutical Use
21 patents (USPTO):Explore Patents
1. 10100030 - Carboxymethyl piperidine derivative (2018-10-16),
2. 10011568 - Cyclohexyl pyridine derivative (2018-07-03),
3. 9708266 - Cyclohexyl pyridine derivative (2017-07-18),
4. 9643969 - (aza)indolizine derivative and pharmaceutical use thereof (2017-05-09),
5. 9115144 - Fused heterocyclic derivative and pharmaceutical use thereof (2015-08-25),
6. 9023882 - 5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same (2015-05-05),
7. 8993616 - (aza)indole derivative and use thereof for medical purposes (2015-03-31),
8. 8829040 - (aza)indole derivative and use thereof for medical purposes (2014-09-09),
9. 8748452 - Indolizine derivative and use thereof for medical purposes (2014-06-10),
10. 8466152 - (aza)indole derivative and use thereof for medical purposes (2013-06-18),
11. 8324176 - Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof (2012-12-04),
12. 8263622 - Fused-ring derivative and medical application of same (2012-09-11),
13. 8227500 - 5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same (2012-07-24),
14. 8003647 - (Aza)indole derivative and use thereof for medical purposes (2011-08-23),
15. 7998975 - Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs (2011-08-16),

Title: Kazuo Shimizu: Innovator in Pharmaceutical Patents

Introduction

Kazuo Shimizu, based in Azumino, Japan, is a notable inventor in the pharmaceutical industry with a total of 21 patents to his name. His work primarily focuses on the development of compounds aimed at addressing critical health issues, particularly those associated with cancer treatment.

Latest Patents

Kazuo's latest innovations include remarkable compounds designed to combat chemotherapy-induced nausea and vomiting. One of his notable patents is a **carboxymethyl piperidine derivative**, which exhibits NK receptor antagonist activity while reducing CYP3A4 inhibitory effects compared to existing solutions like aprepitant. This compound's formula incorporates a benzene ring structure along with specific configurations for carbon and hydrogen atoms, marking significant advancements in pharmaceutical chemistry.

Another significant contribution is his **cyclohexyl pyridine derivative**. This compound similarly targets NK receptor antagonism, offering a new therapeutic avenue for patients suffering from the side effects of cancer chemotherapy. The structural composition involves intricate arrangements of rings and functional groups, presenting a unique solution to an urgent medical challenge.

Career Highlights

Kazuo Shimizu is currently affiliated with Kissei Pharmaceutical Co., Ltd., where he continues to make strides in his research. His dedication to creating innovative pharmaceutical solutions has positioned him as a key player in the industry, propelling advancements in patient care.

Collaborations

Collaboration is at the heart of Kazuo's work, and he frequently engages with talented colleagues such as Masato Iizuka and Masayuki Isaji. Together, they contribute to ongoing projects that explore novel therapeutic agents, showcasing the importance of teamwork in fostering innovation.

Conclusion

Kazuo Shimizu exemplifies the spirit of innovation within the pharmaceutical field. His extensive patent portfolio and significant collaborations highlight his commitment to enhancing treatment options for patients in need. The advancements brought forth by Shimizu not only enrich the field of pharmaceuticals but also hold the potential to considerably improve the quality of life for cancer patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…